855-722-2552If you or a loved one were harmed by taking Oxbryta, you may be entitled to compensation via an individual or class action Oxbryta lawsuit.
Oxbryta (voxelotor), manufactured by Pfizer, is a medication designed to treat sickle cell disease that was approved by the FDA in 2019. In September 2024, it was voluntarily recalled by Pfizer after reports of severe side effects that included increased rates of vaso-occlusive crises (VOCs), hospitalization, and death.
Our medical malpractice attorneys are currently investigating potential claims. If you experienced physical, emotional, or financial damages due to the use of Oxbryta, contact us today for a free consultation regarding your case.
Oxbryta Recall Lawsuit Details
The Oxbryta recall has led to legal investigations on behalf of individuals who claim they were not adequately warned of the risks of the drug.
Oxbryta works by improving the ability of red blood cells to hold onto oxygen, thus improving the health and lifespan of cells and preventing them from becoming misshapen. After approval by the FDA, it was fast-tracked for use in both children and adults with sickle cell disease.
The 2024 global recall of the drug by Pfizer was prompted by reports of painful complications such as VOC, kidney failure, organ damage, stroke, and death. Rates of these complications were higher in patients taking Oxbryta than those taking a placebo.
Ongoing Oxbryta lawsuit actions claim that Pfizer failed to warn about the risks of the drug and is liable for the damages caused by misleading marketing and/or lack of sufficient safety studies.
Our investigation into patient harm and regulatory actions concerning Oxbryta is ongoing. Call now to speak with a pharmaceutical litigation attorney about your experience with Oxbryta and find out if you qualify for an Oxbryta class action lawsuit.
Legal Timeline and Key Events
2019: FDA Approval
In 2019, Oxbryta was approved by the U.S. Federal Drug Administration for use in treating complications of sickle cell disease, with approval extending to children aged 4 to 11 in 2021.
2023-2024: Emerging Safety Concerns
Reports of adverse effects of Oxbryta started gaining attention, prompting increased oversight of Oxbryta side effects and possible long-term harm.
2024-2025: Recalls and Legal Action
Personal injury law firms begin investigating claims around Oxbryta and filing Oxbryta recall lawsuits on behalf of clients and their families.
2025: Current Legal Status
Lawsuits regarding Oxbryta are currently gaining steam in the courts with the potential for the formation of an Oxbryta class action lawsuit.
Who Might Qualify for an Oxbryta Lawsuit Settlement?
Sickle cell disease is an incredibly painful and debilitating illness, made worse for some by the addition of serious complications from use of Oxbryta tablets.
You may be entitled to compensation via an Oxbryta lawsuit settlement if you:
- Were harmed due to the use of Oxbryta: This includes VOC, organ damage, kidney failure, and wrongful death, as well as other serious physical complications.
- Experienced damages as a result of this harm: This could be increased medical expenses, lost wages or earning capacity, emotional harm, pain and suffering, or other types of direct harm caused by the use of Oxbryta.
- Have evidence that demonstrates harm and associated damages: Medical records, prescription records, doctor’s statements, and more are all essential in proving your claim and obtaining compensation.
If you qualify, the next thing to consider is filing an individual claim versus getting involved in a class action suit. In cases against pharmaceutical companies, class action lawsuits are generally preferred since they allow multiple harmed individuals to share resources, evidence, and expert testimony while putting additional pressure on manufacturers. At this time, an Oxbryta class action lawsuit has not yet been filed.
Oxbryta Legal Updates (March 2025)
The first Oxbryta recall lawsuit was filed against Global Blood Therapeutics (GBT), the original creator of Oxbryta, in October 2024 by 67-year-old California resident Trebor Hardiman, who alleged severe complications – including VOC and debilitating pain – from use of the drug. A second lawsuit was filed on behalf of Tirrell Allen of Illinois in November 2024 against GBT and Pfizer, which acquired GBT in 2022.
Since then, more lawsuits have been filed against GBT and Pfizer for failure to warn of the known risks of Oxbryta. Plaintiffs claim that GBT and Pfizer actively concealed the dangers of Oxbryta, promoting the drug despite knowledge that Oxbryta significantly increased risk of death compared to a placebo. No settlements, awards, or verdicts have yet been announced.
How Long Do You Have to File an Oxbryta Lawsuit?
Here in Florida, you have two (2) years from the date the injury should reasonably have been discovered to file a dangerous drug product liability suit.
While it hasn’t been officially announced, the statute of limitations for Oxbryta likely began upon Pfizer’s voluntary global recall, meaning the clock is ticking on filing for damages individually or as part of an Oxbryta class action suit.
Contact Gordon & Partners Law Firm to Learn More
Gordon & Partners Law Firm has served Florida residents for more than 30 years, recovering more than $1 Billion in compensation for our clients. Our experience in pharmaceutical litigation makes us a powerful partner in the fight against drug companies like GBT and Pfizer, and can help you get the compensation you deserve for harm caused by Oxbryta tablets.
We work on a contingency fee basis, so you don’t owe anything until you receive an Oxbryta Settlement, Award, or Verdict. Call now or fill out an online contact form to speak with a lawyer for free about a potential Oxbryta lawsuit.
- We represent the injured, not the powerful
- No legal fees, unless we win your case
- Over 200 years of combined experience
